According to AIM ImmunoTech 's latest financial reports the company's current EPS (TTM) is -$0.40. In 2022 the company made an earnings per share (EPS) of -$0.40 a decrease over its 2021 EPS that were of -$0.40.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.40 | -0% |
2022 | -$0.40 | -0% |
2021 | -$0.40 | -20% |
2020 | -$0.50 | -90.41% |
2019 | -$5.21 | -45.99% |
2018 | -$9.65 | -24.37% |
2017 | -$12.76 | -12.12% |
2016 | -$14.52 | -59.26% |
2015 | -$35.64 | -27.03% |
2014 | -$48.84 | -7.5% |
2013 | -$52.80 | -16.67% |
2012 | -$63.36 | 50% |
2011 | -$42.24 | -11.11% |
2010 | -$47.52 | 12.5% |
2009 | -$42.24 | -50% |
2008 | -$84.48 | -33.33% |
2007 | -$126.72 | -22.58% |
2006 | -$163.68 | 24% |
2005 | -$132.00 | -46.81% |
2004 | -$248.16 | 9.3% |
2003 | -$227.04 | 86.96% |
2002 | -$121.44 | -20.69% |
2001 | -$153.12 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | -$0.27 | -32.50% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | -$1.00 | 150.00% | ๐บ๐ธ USA |